Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

JDS Pharmaceuticals

2004 FOUNDED
PRIVATE STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of services in in the acquisition, development, and marketing of in-line and late-stage developmental pharmaceutical products. The company offers Pexeva for major depressive disorders, panic disorders, and obsessive compulsive disorders; and Lithobid for bipolar disorders. It identifies, develops, and delivers safe medicines.

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 405 Lexington Avenue
  • The Chrysler Building, 59th Floor
  • New York, NY 10174
  • United States

+1 (212) 000-0000

JDS Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore JDS Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

JDS Pharmaceuticals Executive Team (4)

Name Title Board
Seat
Contact
Info
Phillip Satow Chairman & Chief Executive Officer
Daniel Kreisler Vice President

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »

JDS Pharmaceuticals Board Members (4)

Name Representing Role Since Contact
Info
0000000 00000 JDS Pharmaceuticals Chairman & Chief Executive Officer 000 0000

3 Former Board Members

You’re viewing 1 of 4 board members. Get the full list »